Effect of vaccination status on CORADS and computed tomography severity score in hospitalized COVID-19 patients: A retrospective study

Table 5 Distribution of Acute Phase Variables by Groups

		1Unvaccinated	2Single dose CoronoVac	3Single dose BioNTech	4Two doses CoronaVac	5Two doses BioNTech	6Three doses	P valuec	Post Hoc
CRP	mean ± SD	52.95 ± 40.49	49.75 ± 31.26	34.0 ± 32.3	66.58 ± 52.75	84.35 ± 72.99	81 ± 62.88	0.006a	3 < 4, 5, 6
	Median (Min-Max)	46 (3-173)	39.5 (12-124)	22 (2-106)	59 (4-204)	66 (2-341)	54 (2-286)
LDH	mean ± SD	359.17 ± 164.41	315.2 ± 58.2	331.83 ± 116.61	401.5 ± 305.74	294.05 ± 89.57	276.36 ± 94.2	0.001a	6 < 5, 3, 1; 5 < 1
	Median (Min-Max)	359 (164-1213)	311 (195-461)	328 (207-692)	368 (156-1943)	290 (152-640)	273 (131-538)
Lymphocyte count	mean ± SD	1335.4 ± 512.04	1396.5 ± 470.93	1502.92 ± 724.42	1637.11 ± 1896.86	1628.75 ± 86.02	1477.95 ± 867.82	0.660
	Median (Min-Max)	1290 (390-2790)	1375 (510-2050)	1340 (420-3450)	1200 (340-12360)	1575 (550-5200)	1320 (260-4640)
Procalcitonin	mean ± SD	0.52 ± 0.94	0.28 ± 0.29	0.13 ± 0.13	0.77 ± 2.39	0.25 ± 0.2	0.27 ± 0.31	0.001a	3 < 1, 2, 4, 5
	Median (Min-Max)	0.3 (0.1-6)	0.3 (0.1-1.3)	0.1 (0.1-0.7)	0.2 (0.1-15)	0.1 (0.1-0.7)	0.1 (0.1-1.2)
D-DIMER	mean ± SD	1041.08 ± 1559.79	955.95 ± 1156.16	1396.71 ± 1608.97	1561.63 ± 2118.83	1462.2 ± 2934.47	1388.41 ± 1922.45	0.106
	Median (Min-Max)	596 (24-11805)	549.5 (133-4661)	714.5 (140-6193)	942.5 (251-13077)	622 (166-17459)	820 (194-9440)

^aP < 0.01.

^cKruskal Wallis test & post hoc Dunn test.